TTNP - Titan Pharmaceuticals Inc. Market Cap to Sales Volume

Brandmark of Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals is establishing strategic partnerships to integrate ProNeura systems into addiction therapy. The company's capitalization is based on the implementation of long-acting implants. The price-to-sales ratio dynamics reflect current market phases, where the parameter value equals 43.80. The firm's environmental policy remains formal, limited to standard waste disposal within its laboratory complexes.

Price-to-Revenue Ratio: Titan Pharma (TTNP) for 07/04/2022 - 08/16/2024

Metric breakdowns and analytics for Titan Pharmaceuticals (TTNP)

- price and consensus price forecast:
Market Chart titanpharm.com|TTNP - Consensus Target
- market capitalization statistics:
Market Value Titan Pharma|TTNP - Enterprise Value
- book capitalization information:
Book Value per Share Titan Pharmaceuticals|TTNP - Company Book Value|Capitalization to Book Value Ratio titanpharm.com|TTNP - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Titan Pharmaceuticals|TTNP - Long-Term Debt to Equity|Current Liabilities to Equity titanpharm.com|TTNP - Company Aggregate Debts|Debt to Net Assets Ratio Titan Pharma|TTNP - Company Long-Term Debts|Company Short-Term Debts Titan Pharmaceuticals|Intermediate Coverage Ratio titanpharm.com
- company profitability and valuation multiples indicators:
TTNP - Company Net Income|Future Profit Titan Pharmaceuticals|TTNP - P/E Multiple|Forward P/E Multiple titanpharm.com|TTNP - PEG Multiple|Enterprise Value to EBITDA Ratio Titan Pharma|TTNP - Operating profit EBITDA|Net earnings per one share for the last twelve months Titan Pharmaceuticals|TTNP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth titanpharm.com|TTNP - Net earnings per share growth this year|Projected earnings per share increase next year Titan Pharmaceuticals
- total revenue and sales volume data:
TTNP - Revenue and Sales Volume|Company Future Sales titanpharm.com|TTNP - P/S Multiple|Forward Price-to-Revenue Multiple Titan Pharma
General company analysis:Titan Pharmaceuticals Inc., TTNP
Finished products of Titan Pharmaceuticals

Titan Pharmaceuticals maintains a high business valuation driven by its technological advantage in developing ProNeura implants for long-term drug release. GURU.Markets analysts utilize the enterprise value-to-revenue ratio to determine the premium paid for every dollar of sales and identify the risk of overpayment relative to industry norms, monitoring the stability of this balance on the chart.

Competing companies

Price-to-Revenue Coefficient indivior.com|Collegium Pharmaceutical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume CRON (Cronos Group Inc)|Tweed - P/S Multiple|HITI - P/S Multiple|auroramj.com (ACB) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio ACHV|Market Cap to Revenue SKYE|ANEB: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio InterCure Ltd. (INCR)|NTRB: Price-to-Sales Ratio|P/S Multiple NSRX (Nasus Pharma)|Market Capitalization-to-Revenue Ratio IGC|MIRA Pharma - P/S Multiple|FLGC - P/S Multiple|imcannabis.com (IMCC) - Price-to-Revenue Ratio|Adial Pharmaceuticals, Inc. - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Artelo Biosciences Inc.|Market Cap to Revenue Ensysce (ENSC)|P/S Multiple GNLN|P/S Multiple InMed Pharmaceuticals Inc (INM)|P/S Multiple AKAN (Akanda Corporation)|ENVB - Market Cap to Revenue|Bright Green Corp - P/S Multiple|Price to Sales Hempacco Co Inc.